Status:
ACTIVE_NOT_RECRUITING
External Iliac Artery Endofibrosis in Cycling
Lead Sponsor:
Jesus Torres
Conditions:
Iliac Artery Occlusive Disease
Blood Flow Velocity
Eligibility:
MALE
18+ years
Brief Summary
A data request will be made regarding the tests conducted by the subject related to their performance, as well as the results of the medical diagnostic tests performed. The requested data/variables pe...
Detailed Description
The medical tests include those performed during the diagnostic process of the pathophysiology of external iliac artery endofibrosis: imaging tests (Doppler ultrasound), exercise stress tests, compute...
Eligibility Criteria
Inclusion
- Clinical diagnosis of external iliac artery endofibrosis confirmed by medical imaging (e.g., Doppler ultrasound, CT scan, or IVUS).
- Age between 18 and 65 years.
- Must be a regular cyclist (at least 500 training sessions per year for the past 5 years).
- Ability to complete physical performance tests (e.g., cycling power output measurements, Lactate Threshold test).
- No prior surgical intervention for external iliac artery endofibrosis or other lower extremity diseases
- Willingness to provide informed consent and participate in the study.
Exclusion
- History of major cardiovascular disease (e.g., heart attack, stroke).
- Pregnancy or breastfeeding.
- Use of medications that significantly affect vascular health (e.g., anticoagulants, steroids).
- Uncontrolled diabetes or other chronic metabolic disorders.
- Recent lower extremity surgery (within the last 6 months).
- Any condition that could interfere with the performance tests (e.g., neurological disorders, severe joint pain).
- Diagnosis of other vascular diseases (e.g., deep vein thrombosis, atherosclerosis) that could affect arterial function.
- History of systemic or local infections that may impact the vascular system.
- History of significant trauma or injury to the lower extremities (e.g., fractures, ligament tears).
- Any condition preventing safe participation in physical tests, including severe cardiovascular or musculoskeletal limitations.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT07194330
Start Date
August 1 2025
End Date
September 30 2027
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
C San Bartolome 4
Estella-Lizarra, Navarre, Spain, 31292